Since airway hyperresponsiveness is not observed in S1P3-deficient mice, S1P3 receptor antagonists may bring a novel therapeutic strategy for inhibiting airway hyperresponsiveness, which is related to asthma severity [175]. Here, S1PR3 is linked to airway hyperresponsiveness.